Effectiveness of botulinum toxin treatment and rehabilitation program in lateral axial dystonia in Parkinson's disease

2014 ◽  
Vol 40 ◽  
pp. S20-S21
Author(s):  
M. Bacchini ◽  
G. Chiari ◽  
C. Lapiana ◽  
M. Rossi
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Rehabilitation Program ◽  
Botulinum Toxin Treatment

scholarly journals Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment

2005 ◽  
Vol 22 (10) ◽  
pp. 997-1003 ◽  
Author(s):  
F. CADEDDU ◽  
A. R. BENTIVOGLIO ◽  
F. BRANDARA ◽  
G. MARNIGA ◽  
G. BRISINDA ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Treatment

scholarly journals Outcome on Balance and Gait Following Botulinum Toxin Treatment for Striatal Foot in Parkinson's Disease

2016 ◽  
Vol 4 (3) ◽  
pp. 309-315 ◽  
Author(s):  
Beata Lindholm ◽  
Anders Beckman ◽  
Wojciech Duzynski ◽  
Eva Ekvall Hansson
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Treatment

Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson’s disease

2009 ◽  
Vol 257 (1) ◽  
pp. 139-141 ◽  
Author(s):  
Andrea Santamato ◽  
Maurizio Ranieri ◽  
Francesco Panza ◽  
Stefano Zoccolella ◽  
Vincenza Frisardi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Rehabilitation Program ◽  
Pisa Syndrome

Effects of Onabotulinum Toxin A on Gait in Parkinson’s Disease Patients with Foot Dystonia

2021 ◽  
pp. 1-6
Author(s):  
Pei Huang ◽  
Yuan-Yuan Li ◽  
Jung E. Park ◽  
Ping Huang ◽  
Qin Xiao ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Gait Analysis ◽  
Rating Scale ◽  
Analog Scale ◽  
Toxin A ◽  
Timed Up And Go ◽  
Balance Test ◽  
Onabotulinum Toxin A

ABSTRACT: We investigated the effects of botulinum toxin on gait in Parkinson’s disease (PD) patients with foot dystonia. Six patients underwent onabotulinum toxin A injection and were assessed by Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS), visual analog scale (VAS) of pain, Timed Up and Go (TUG), Berg Balance Test (BBT), and 3D gait analysis at baseline, 1 month, and 3 months. BFMDRS (p = 0.002), VAS (p = 0.024), TUG (p = 0.028), and BBT (p = 0.034) were improved. Foot pressures at Toe 1 (p = 0.028) and Midfoot (p = 0.018) were reduced, indicating botulinum toxin’s effects in alleviating the dystonia severity and pain and improving foot pressures during walking in PD.

Sign in / Sign up

Export Citation Format

Share Document